Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Memorial Sloan Kettering Cancer Center
Instituto de Investigación Biomédica de Salamanca
University of Texas Southwestern Medical Center
New York Medical College
Children's Hospital of Philadelphia
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
University of Florida
University of Pittsburgh
Mayo Clinic
Beijing Tongren Hospital
National University Hospital, Singapore
Hackensack Meridian Health
PedAL BCU, LLC
Hackensack Meridian Health
Fred Hutchinson Cancer Center
Affiliated Hospital of Nantong University
Shenzhen University General Hospital
Fudan University
University of Iowa
Peking University People's Hospital
Children's Hospital of Philadelphia
Medical University of South Carolina
City of Hope Medical Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Chinese PLA General Hospital
City of Hope Medical Center
M.D. Anderson Cancer Center
University of Chicago
Jonsson Comprehensive Cancer Center
Beijing GoBroad Hospital
Big Ten Cancer Research Consortium
University of California, San Diego
University of Chicago
Penn State University
M.D. Anderson Cancer Center
Medical College of Wisconsin
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Seattle Children's Hospital
Essen Biotech
Memorial Sloan Kettering Cancer Center